Patients With Rheumatoid Arthritis Frequently Have Persisting Pain

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 10, 2024 -- Patients with rheumatoid arthritis (RA) undergoing standard-of-care treatment frequently have persisting pain, according to a study published online Sept. 30 in the Annals of the Rheumatic Diseases.

Christoph Baerwald, M.D., Ph.D., from the University Hospital Leipzig in Germany, and colleagues conducted a prospective multicenter study including outpatients with RA scheduled for escalation of anti-inflammatory treatment due to active disease and severe pain. A total of 567 patients were stratified into a reference group, nonresponders group, and persisting pain group at week 24 (59.4, 18.0, and 22.6 percent, respectively). The former two subgroups ended the study at week 24, and the third continued until week 48.

At week 24, 8.8, 35.0, and 26.5 percent of responders, nonresponders, and those with persisting pain, respectively, tested positive for neuropathic pain (NeP). The researchers found a positive association between pain catastrophizing and number of tender joints with persisting pain at week 24. There was no association for baseline painDETECT Questionnaire scores with subsequent persisting pain.

"From the findings of our study, it is evident that persisting pain and NeP (as well as potential nociplastic pain) are frequently found in patients with RA undergoing standard-of-care treatment," the authors write.

Several authors disclosed ties to pharmaceutical companies, including AbbVie, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-11 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords